v3.26.1
Overview of Consolidation Scope (Tables)
12 Months Ended
Dec. 31, 2025
Disclosure of subsidiaries [abstract]  
Schedule of details of consolidated entities Details of the Company’s consolidated entities at
the end of the reporting period are as follows:
Name
   
 
Country
   
 
Participation
argenx SE
the Netherlands
100%
argenx B.V.
Belgium
100%
argenx Benelux B.V.
Belgium
100%
argenx US, Inc.
USA
100%
argenx Australia Pty. Ltd.
Australia
100%
argenx Austria Services GmbH
Austria
100%
argenx Brasil Produtos Farmacêuticos Ltda
Brazil
100%
argenx Canada Inc.
Canada
100%
argenx France SAS
France
100%
argenx Germany GmbH
Germany
100%
argenx Italy S.r.l.
Italy
100%
argenx Japan KK.
Japan
100%
argenx Netherlands Services B.V.
the Netherlands
100%
argenx Spain S.L.
Spain
100%
argenx Spain S.L. - Sucursal em Portugal
Portugal
100%
argenx Switzerland, S.A.
Switzerland
100%
argenx UK Ltd.
United Kingdom
100%
Broteio Pharma B.V.
the Netherlands
100%